Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis | Zendy

Suzanne M. Marks | Zendy; Sundari Mase | Zendy; Sapna Bamrah Morris | Zendy

Open Access

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

Author(s) -

Suzanne M. Marks,

Sundari Mase,

Sapna Bamrah Morris

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix208

Subject(s) - medicine , discontinuation , latent tuberculosis , tuberculosis , pyrazinamide , incidence (geometry) , ethambutol , regimen , meta analysis , confidence interval , adverse effect , mycobacterium tuberculosis , pathology , physics , optics

Evidence-based recommendations for treating persons having presumed latent tuberculosis (LTBI) after contact to infectious multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small observational studies. Tuberculosis incidence in persons treated for latent MDR -TB infection is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research